Filing Details
- Accession Number:
- 0001209191-15-052267
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-11 16:02:56
- Reporting Period:
- 2015-06-09
- Filing Date:
- 2015-06-11
- Accepted Time:
- 2015-06-11 16:02:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1350360 | Jason Cole | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | Svp, Secy. & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-09 | 2,000 | $22.53 | 2,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-06-09 | 132 | $188.24 | 1,868 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-09 | 447 | $187.72 | 1,421 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-09 | 368 | $186.60 | 1,053 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-09 | 381 | $185.53 | 672 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-09 | 672 | $184.62 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-06-09 | 2,000 | $0.00 | 2,000 | $22.53 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
79,000 | 2024-02-10 | No | 4 | M | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 7, 2014
- The range in prices for the transaction reported on this line was $188.16 to $188.61. The average weighted price was $188.2367. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $187.00 to $187.96. The average weighted price was $187.7204. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $186.00 to $186.83. The average weighted price was $186.5956. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $185.12 to $185.85. The average weighted price was $185.5273. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $184.31 to $184.88. The average weighted price was $184.6206. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests over a four-year period, at a rate of twenty-five percent (25%) on March 6, 2015 and in 36 equal monthly installments thereafter.